HopeStage
Back to all studies
CompletedNCT00136786

Memantine or bupropion in a laboratory model of smoking relapse

About this titleRead the official source — NCT00136786
Placebo comparisonAges 21–45United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 45 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2006
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 45 Years
Official registry ID
NCT00136786
Official title
Show the full official title

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Memantine.

Who was this study for?

Listed age limits: 21 years to 45 years.

Want to explore more studies?

Explore studies